Investments of €2m in SurgaColl
The investment in SurgaColl Technologies brings to €2m the total investment in the company from a funding syndicate which includes AIB Seed Capital Fund, Harmac Medical Products, Enterprise Ireland, and private investors from Britain, France, and Singapore.
SurgaColl, which is based in the Rubicon Centre in CIT, was set up in 2010 to commercialise a portfolio of implantable orthopaedic products developed by the Tissue Engineering Research Group at the Royal College of Surgeons.
